Xylazine is an agonist at kappa opioid receptors and exhibits sex-specific responses to opioid antagonism
Article in Addiction Neuroscience (June 2024)
The most recent citing publications are shown below. View all 41 publications that cite this research output on Dimensions.
Article in Addiction Neuroscience (June 2024)
Article in American Journal of Psychiatry (April 2024)
Article in Experimental and Clinical Psychopharmacology (April 2024)